"Resorcinols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A water-soluble crystalline benzene-1,3-diol (resorcinol) and its derivatives.
Descriptor ID |
D012118
|
MeSH Number(s) |
D02.455.426.559.389.657.852
|
Concept/Terms |
Resorcinols- Resorcinols
- m-Dihydroxybenzenes
- m Dihydroxybenzenes
- meta-Dihydroxybenzenes
- meta Dihydroxybenzenes
|
Below are MeSH descriptors whose meaning is more general than "Resorcinols".
Below are MeSH descriptors whose meaning is more specific than "Resorcinols".
This graph shows the total number of publications written about "Resorcinols" by people in this website by year, and whether "Resorcinols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Resorcinols" by people in Profiles.
-
Jett JE, McLaughlin M, Lee MS, Parish LC, DuBois J, Raoof TJ, Tabolt G, Wilson T, Somerville MC, DellaMaestra W, Piscitelli SC. Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics. Am J Clin Dermatol. 2022 Jan; 23(1):83-91.
-
Bobrov E, Skobeleva N, Restifo D, Beglyarova N, Cai KQ, Handorf E, Campbell K, Proia DA, Khazak V, Golemis EA, Astsaturov I. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Oncotarget. 2017 Jan 17; 8(3):4399-4409.
-
Armstrong H, Wolmarans A, Mercier R, Mai B, LaPointe P. The co-chaperone Hch1 regulates Hsp90 function differently than its homologue Aha1 and confers sensitivity to yeast to the Hsp90 inhibitor NVP-AUY922. PLoS One. 2012; 7(11):e49322.
-
Elliott MB, Tuma RF, Amenta PS, Barbe MF, Jallo JI. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma. 2011 Jun; 28(6):973-81.
-
Katin MJ, Teehan BP, Sigler MH, Schleifer CR, Gilgere GS. Resorcinol-induced hypothydroidism in a patient on chronic hemodialysis. Ann Intern Med. 1977 Apr; 86(4):447-9.